Vesicle Therapeutics Inc.

Biotechnology company · Niwot, Colorado, United States

Vesicle Therapeutics Inc. is a biotechnology company headquartered in Niwot, Colorado, United States. Its earliest recorded incorporation is in 2020. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $1.6 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $800,000 sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Vesicle Therapeutics at a glance

Typebiotechnology company
HeadquartersNiwot, Colorado, United States
Earliest incorporation on record2020
Employees (self-reported, 2025)2
SEC CIK1922980

What does Vesicle Therapeutics do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $1.6 million in total (2022 to 2025). NIH funding came from the National Heart, Lung, and Blood Institute, National Cancer Institute.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $800,000 sold (2022).

Frequently asked questions about Vesicle Therapeutics

Where is Vesicle Therapeutics headquartered?

Vesicle Therapeutics Inc. is headquartered in Niwot, Colorado, United States.

What does Vesicle Therapeutics do?

Vesicle Therapeutics Inc. is a biotechnology company.

When was Vesicle Therapeutics founded?

The earliest incorporation on record for Vesicle Therapeutics Inc. is in 2020, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences